Melanoma development and progression: A conspiracy between tumor and host

Differentiation

Volumn 70, Issue 9-10, 2002, Pages 522-536

  Hsu, Mei Yu ^a,b,c   Meier, Friedegund ^a,d   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cadherin; Chemokine; Endothelial cell; Fibroblast; Gap junction; Growth factor; Keratinocyte; Matrix metalloproteinase; Melanocyte; MelCAM MUC18 CD146

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA3 INTEGRIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; MELANOMA ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE CELL ADHESION MOLECULE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

CANCER GROWTH; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CELL INTERACTION; DERMOEPIDERMAL JUNCTION; GAP JUNCTION; HOST CELL; HUMAN; KERATINOCYTE; LEUKEMIA; MELANOCYTE; MELANOMA; MICROENVIRONMENT; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

EID: 0036993573     PISSN: 03014681     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-0436.2002.700906.x     Document Type: Review

References (121)

1. Aho, S., Levansuo, L., Montonen, O., Kari, C., Rodeck, U. and Uitto, J. (2002) Specific sequences in p120ctn determine subcellular distribution of its multiple isoforms involved in cellular adhesion of normal and malignant epithelial cells. J Cell Sci 115:1391-1402.
2. Alper, O., De Santis, M.L., Stromberg, K., Hacker, N.F., Cho Chung, Y.S. and Salomon, D.S. (2000) Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion, and tumorigenicity in ovarian cancer cells. Int J Cancer 88:566-574.
3. Anfosso, F., Bardin, N., Frances, V., Vivier, E., Camoin-Jau, L., Sampol, J. and Dignat-George, F. (1998) Activation of human endothelial cells via S-endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125(FAK). J Biol Chem 273:26852-26856.
4. Atillasoy, E.S., Seykora, J.T., Soballe, P.W., Elenitsas, R., Nesbit, M., Elder, D.E., Montone, K.T., Sauter, E. and Herlyn, M. (1998) UVB induces atypical melanocytic lesions and melanoma in human skin. A J Pathol 152:1179-1186.
5. Bafetti, L.M., Young, T.N., Itoh, Y. and Stack, M.S. (1998) Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of meltalloproteinase-2 expression and enhanced cellular invasion by melanoma cells. J Biol Chem 273:143-149.
6. Balaban, G.B., Herlyn, M., Clark, W.H., Jr. and Nowell, P.C. (1986) Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet 19:113-122.
7. Balaban, G., Herlyn, M., Guerry, D IV, Bartolo, R., Koprowski, H., Clark, W.H. and Nowell, P.C. (1984) Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 11:429-439.
8. Bar-Eli, M (1999) Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 67:12-18.
9. Bardeesy, N., Wong, K.K., DePinho, R.A. and Chin, L. (2000) Animal models of melanoma: recent advances and future prospects. Adv Cancer Res 79:123-156.
10. Bardin, N., Anfosso, F., Masse, J.M., Cramer, E. Sabatier, F., Le Bivic, A., Sampol, J. and Dignat-George, F. (2001) Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 98:3677-3684.
11. Bardin, N., George, F., Mutin, M., Brisson, C., Horschowski, N., Frances, V., Lesaule, G. and Sampol, J. (1996) S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 4:531-539.
12. Bechetoille, N., Haftek, M., Staquet, M.J., Cochran, A.J., Schmitt, D. and Berthier-Vergnes, O. (2000) Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissociation of native collagen type IV and VII. Melanoma Res 10:427-434.
13. Bergers, G., Javaherian, K., Lo, K.M., Folkmanm, J. and Hanahan, D. (1999) Effects of angiogenesis inhibitors on multistage carcinomagenesis in mice. Science 284:808-812.
14. Berking, C., Takemoto, R., Dinder, R.L., Hartman, S.M., Ruiter, D.J., Gallagher, P.M., Lessin, S.R. and Herlyn, M. (2002) Photocarcinogenesis in human adult skin grafts. Carcinogenesis 23:181-187.
15. Berking, C., Takemoto, R., Satyamoorthy, K., Elenitsas, R. and Herlyn, M. (2001a) Basic fibroblast growth factor and UVB transform melanocytes in human skin. Am J Pathol 158:943-953.
16. Berking, C., Takemoto, R., Schaider, H., Showe, L., Satyamoorthy, K., Robbins, P. and Herlyn, M. (2001b) TGF-β1 increases survival of human melanoma through stroma remodeling. Cancer Res 61:8306-8316.
17. Bessou, S., Surleve-Bazeille, J.E., Pain, C., Donatien, P. and Taieb, A. (1996) Ex vivo study of skin phenotypes. J Invest Dermatol 107:684-688.
18. Biggs, M.W. and Eiselein, J.E. (2001) Suppression of immune surveillance in melanoma, Med Hypotheses 56:648-652.
19. Brown, P.D. (1999) Clinical studies with matrix metalloproteinase inhibitors. APMIS 107:174-180.
20. Brown, P.D. (2000) Ongoing trials with matrix metalloproteinase inhibitors. Expert Opin Investig Drugs 9:2167-2177.
21. Brown, P.D. (2001) New hope for matrix metalloproteinase inhibitors in cancer therapy. Drug Discov Today 6:615.
22. Cario-Andre, M., Pain, C., Gall, Y., Ginestar, J., Nikaido, O. and Taieb, A. (2000) Studies on epidermis reconstructed with and without melanocytes: melanocytes prevent sunburn cell formation but not appearance of DNA damaged cells in fair-skinned Caucasians. J Invest Dermatol 115:193-199.
23. Chiba, A (2001) Precision networking: a look through the eyes of a fly. Neuron 32:381-384.
24. Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J.W. II and DePinho, R.A. (1997) Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev 11:2822-2834.
25. Clark, W.H. (1991) Tumor progression and the nature of cancer. Br J Cancer 64:631-644.
26. Conrad, C.T., Ernst, N.R., Dummer, W., Brocker, E.B. and Becker, J.C. (1999) Differential expression of transforming growth factor β1 and interleukin 10 in progressing and regressing areas of primary melanoma. J Exp Clin Cancer Res 18:225-232.
27. Danø, K., Romer, J., Nielsen, B.S., Bjorn, S., Pyke, C., Rygaard, J., and, Lund, L.R., 1999 (Cancer invasion and tissue remodeling cooperation of protease system and cell types.) Cancer invasion and tissue remodeling-cooperation of protease systems and cell types. APMIS 107:120-127.
28. Deryugina, E.I., Bourdon, M.A., Jungwirth, K., Smith, J.W. and Strongin, A.Y. (2000) Functional activation of integrin αvβ3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer 86:15-23.
29. D'Souza, B and Taylor-Papadimitriou, J. (1994) Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc Natl Acad Sci USA 91:7202-7206.
30. Eisinger, M and Marko, O. (1982) Selective proliferation of normal human melanocytes in vitro in the presence of phobol ester and cholera toxin. Proc Natl Acad Sci USA 79:2018-2022.
31. Elder, D.E., Rodeck, U., Thurin, J., Cardillo, F., Clark, W.H. and Stewart, R. (1989) Antigenic profile of tumor progression in human melanocytic nevi and melanomas. Cancer Res 49:5091-5096.
32. Eves, P., Layton, C., Hedley, S., Dawson, R.A., Wagner, M., Morandini, R., Ghanem, G. and MacNeil, S. (2000) Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin. Br J Dermatol 142:210-222.
33. Fielding, J., Scholefield, J., Stuart, R., Howkins, R., McCulloch, P., Maughan, T., Seymour, M., Van Cutsem, E., Thorlacius-Ussing, O. and Hovnanian, A. (2000) A randomized double-blind placebo-controlled study of marimistat in patients with inoperable gastric adenocarcinoma. Proc Am Soc Clin Oncol 19:240A.
34. Fitzpatrick, T.B., Szabo, G., Seiji, M. and Quved, W.C. Jr (1979) Biology of the melanin pigmentary system. In: Fitzpatrick T.B., Else A.Z., Wolf K., Freedberg I.M., Ansten, K.F. (eds) Dermatology in general medicine, 2nd ed. McGraw-Hill, New York, pp 131.
35. Forsberg, K., Valyi-Nagy, I., Heldin, C.H., Herlyn, M. and Westermark, B. (1993) Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci USA 90:392-397.
36. Fukata, M., Nakagawa, M., Kuroda, S. and Kaibuchi, ,K. (1999) Cell adhesion and Rho small GTPases. J Cell Sci 112:4491-4500.
37. Garcia-Hernandez, M.L., Hernandez-Pando, R., Gariglio, P. and Berumen, J. (2002) Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumor and vascular cell proliferation. Immunology 105:231-243.
38. Gottardi, C.J. and Gumbiner, B.M. (2001) Adhesion signaling: how beta-catenin interacts with its partners. Curr Biol 11:R792-794.
39. Halaban, R (1996) Growth factors and melanomas. Semin Oncol 23:673-681.
40. Halaban, R., Rubin, J.S. and White, W. (1993) Met and HGF-SF in normal melanocytes and melanoma cells. Experientia (suppl) 65:329-339.
41. Hendrix, M.J.C., Seftor, E.A., Meltzer, P.S., Gardner, L.M.G., Hess, A.R., Kirschmann, D.A., Schateman, G.C. and Seftor, R.E.B. (2001) Proc Natl Acad Sci USA 98:8018-8023.
42. Herlyn, M., Rodeck, U., Mancianti, M.L., Cardillo, F.M., Lang, A., Ross, A.H., Jambrosic, J. and Koprowski, H. (1987) Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. Cancer Res 47:3057-3061.
43. Herlyn, M and Satyamoorthy, K. (2000) Molecular biology of cutaneous melanoma. In: DeVita, V.T. Jr, Hellman S., Rosenberg, S.A. (eds) Cancer: Principles and Practice of Oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp pp 2003-2012.
44. Herlyn, M and Shih, I.-M. (1994) Interactions of melanocytes and melanoma cells with the microenvironment. Pigment Cell Res 7:81-88.
45. Hofmann, U.B., Westphal, J.R., Van Muijen, G.N. and Ruiter, D.J. (2000a) Matrix metalloproteinases in human melanoma. J Invest Dermatol 115:337-344.
46. Hofmann, U.B., Westphal, J.R., Waas, E.T., Becker, J.C., Ruiter, D.J. and van Muijen, G.N. (2000b) Coexpression of integrin αvβ3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression. J Invest Dermatol 115:625-632.
47. Hsu, M.-Y., Andl, T., Li, G., Meinkoth, J.L. and Herlyn, M. (2000b) Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 113:1535-1542.
48. Hsu, M.-Y., Meier, F., Nesbit, M., Hsu, J.-Y. and Herlyn, M. (2000a) E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 156:1515-1525.
49. Hsu, M.-Y., Shih, D.-T., Meier, F.E., Van Belle, P., Hsu, J.-Y., Elder, D.E., Buck, C.A. and Herlyn, M. (1998) Adenoviral gene transfer of β3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol 153:1435-1442.
50. Hsu, M.-Y., Wheelock, M.J., Johnson, K.R. and Herlyn, M. (1996) Shifts in Cadherin profiles between human normal melanocytes and melanomas. J Invest Dermatol, Symp Proc 1:188-194.
51. Iruela-Arispe, M.L. and Sage, E.H. (1993) Endothelial cells exhibiting angiogenesis in vitro proliferation in response to TGF-β1. J Cell Biochem 52:414-430.
52. Janji, B., Melchior, C., Gouon, V., Vallar, L. and Kieffer, N. (1999) Autocrine TGF-β-regulated expression of adhesion receptors and integrin-linked kinse in HT-144 melanoma cells correlates with their metastatic phenotype. Int J Cancer 83: 255-262.
53. Javaherian, A., Vaccariello, M., Fusenig, N.E. and Garlick, J.A. (1998) Normal keratinocytes suppress early stage of neoplastic progression in stratified epithelium. Cancer Res 58:2200-2208.
54. Jawhari, A.V., Farthing, M.J. and Pignatelli, M. (1999) The E-cadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation. J Pathol 187:155-157.
55. Johnson, J.P., Rummel, M.M., Rothbacher, U. and Sers, C. (1996) MUC18: A cell adhesion molecule with a potential role in tumor growth and tumor cell dissemination. Curr Top Microbiol Immunol 213:95-105.
56. Juhasz, I., Albelda, S.M., Elder, D.E., Murphy, G.F., Adachi, K., Herlyn, D., Valyi-Nagy, I.T. and Herlyn, M. (1993) Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol 143:528-537.
57. Juliano, R.L. (2002) Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin superfamily members. Annu Rev Pharmacol Toxicol 42:283-323.
58. Kanter-Lewenstohn, L., Dricu, A., Wang, M., Wejde, J., Kiessling, R. and Larsson, O. (1998) Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target. Melanoma Res 8:389-397.
59. Knudsen, K.A., Soler, A.P., Johnson, K.R. and Wheelock, M.J. (1995) Interaction of α-actinin with the cadherin/catenin cell-cell adhesion complex via α-catenin. J Cell Bol 130:67-77.
60. Kotelevets, L., van Hengel, J., Bouyneel, E., Mareel, M., von Roy, F. and Chastre, E. (2001) The lipid phosphatases activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness. J Cell Biol 155:1129-1135.
61. Kraemer, K.H. and Greene, M.H. (1985) Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma. Dermatol Clin 3:225-237.
62. Kraus, A., Masat, L. and Johnson, J.P. (1997) Analysis of the expression of intercellular adhesion molecule-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen. Melanoma Res Suppl 2: S75-81.
63. Kunisada, T., Yamazaki, H., Hirobe, T., Kamei, S., Omoteno, M., Tagaya, H., Hemmi, H., Koshimizu, U., Nakamura, T. and Hayashi, S.I. (2000) Keratinocytes expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis. Mech Dev 94: 67-78.
64. Kurschat, P., Zigrino, P., Nischt, R., Breitopf, K., Steurer, P., Klein, C.E., Krieg, T. and Mauch, C. (1999) Tissue inhibitor of matrix metalloprotease-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type-1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem 274:21056-21062.
65. Lazar-Molnar, E., Hegyesi, H., Toth, S. and Falus, A. (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12:547-554.
66. Letterio, J.J. and Roberts, A.B. (1998) Regulation of immune responses by TGF-β. Annu Rev Immunol 16:137-161.
67. Li, G and Herlyn, M. (2000) Dynamics of intercellular communication during melanoma development. Molecular Med Today 6:163-169.
68. Li, G., Satyamoorthy, K. and Herlyn, M. (2001) N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61:3819-3825.
69. Li, G., Schaider, H., Satyamoorthy, K., Hanakawa, Y., Hashimoto, K. and Herlyn, M. (2002) Downregulation of E-cadherin and desmoglein 1 by hepatocyte growth factor during melanoma development. Oncogene 20:8125-8135.
70. Liotta, L.A. and Kohn, E.C. (2001) The microenvironment of the tumor-host interface. Nature 411:375-379.
71. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., Wu, Y., Hicklin, D., Zhu, Z., Hackett, N.R., Crystal, R.G., Moore, A., Hajjar, K.A., Manova, K., Benezra, R. and Rafii, S. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194-1201.
72. Maniotis, A.J., Folberg, R., Hes, A., Seftor, E.A., Gradner, L.M.G., Pe'er, J., Trent, J.M., Meltzer, P.S. and Hendrix, M.J.C. (1999) Vascular channel formation by human melanoma cells in vivo and in vitro. Am J Pathol 155:739-752.
73. Matsumoto, K., Tajiman, H. and Nakamura, T. (1991) Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem Biophys Res Commun 176:45-51.
74. Meier, F., Caroli, U., Satyamoorthy, K., Schittek, B., Bauer, J., Berking, C., Möller, H., Maczey, E., Rassner, G., Herlyn, M. and Garbe, C. (2002) Basic fibroblast growth factor but not Mel-CAM and/or β3 integrin promotes progression of melanocytes to melanoma. Exp Dermatol, in press.
75. Meier, F., Nesbit, M., Hsu, M.Y., Martin, B., Van Belle, P., Elder, D.E., Schaumburg-Lever, G., Garbe, C., Walz, T.M., Crombleholme, T. and Herlyn, M. (2000) Human melanoma progression in skin reconstructs: Biological significance of bFGF. Am J Pathol 156:193-200.
76. Morimoto, C and Tachibana, K. (1996) Beta 1 integrin-mediated signaling in human T cells. Hum Cell 9:163-168.
77. Morin, P.J. (1999) β-catenin signaling and cancer. BioEssays 21:1021-1030.
78. Mueller, B.M. (1996) Different roles for plasminogen activators and metalloproteinases in melanoma metastasis. Curr Top Microbiol Immunol 213:65-80.
79. Murakami, T., Toda, S., Fujimoto, M., Ohtsuki, M., Byers, H.R., Etoh, T. and Nakagawa, H. (2001) Constitutive activation of Wnt/β-catenin signaling pathway in migration-active melanoma cells - role of LEF-1 in melanoma with increased metastatic potential. Biochem Biophys Res Commun 288:8-15.
80. Nelson, A.R., Fungleton, B., Rothenberg, M.L. and Matrisian, L.M. (2000) The matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 19:1135-1149.
81. Nesbit, M., Schaider, H., Miller, T. and Herlyn, M. (2001) Low-level MCP-1 stimulation of monocytes leads to tumor formation in non-tumorigenic melanoma cells. J Immunol 166:6483-6490.
82. Noonan, F.P., Recio, J.A., Takayama, H., Duray, P., Anver, M.R., Rush, W.L., De Fabo, E.C. and Merlino, G. (2001) Neonatal sunburn and melanoma in mice. Nature 413:271-272.
83. Otsuka, T., Takayama, H., Sharp, R., Celli, G., LaRochelle, W.J., Bottaro, D.P., Ellmore, N., Vieira, W., Owens, J.W., Anver, M. and Merlino, G. (1998) c-met autocrine induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res 58:5157-5167.
84. Paget, S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:571-573.
85. Pickl, W.F., Majdic, O., Fischer, G.F., Petzelbauer, P., Fae, J., Waclavicek, M., Stockkl, J., Scheinecker, C., Vidicki, T., Aschauer, H., Johnson, J.P. and Knapp, W. (1997) MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol 158:2107-2115.
86. Poser, I., Domínguez, D., de Herreros, A.G., Varnai, A., Buettner, R. and Bosserhoff, A.K. (2001) Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 276:24661-24666.
87. Rafii, S (2000) Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 105:17-19.
88. Reynolds, A.B., Danieal, J.M., Mo, Y.Y., Wu, J. and Zhang, Z. (1996) The novel catenin p120cas binds classical cadherins and induces an unusual morphological phenotype in NIH3T3 fibroblasts. Exp Cell Res 225:328-337.
89. Rimm, D.L., Caca, K., Hu, G., Harrison, F.B. and Fearon, E.R. (1999) Frequent nuclear/cytoplasmic localization of β-catenin without exon 3 mutations in malignant melanoma. Am J Path 154:325-329.
90. Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefield, L.M., Heine, U.I., Liotta, L.A., Falanga,V., Kehrl, J.H. and Fauci, A.S. (1986) Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171.
91. Rodeck, U., Herlyn, M., Menssen, H.D., Furlanetto, R.W. and Koprowski, H. (1987) Metastatic but not primary melanoma cells grow in vitro independently of exogenous growth factors. Int J Cancer 40:687-690.
92. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E. and Polakis, P. (1997) Stabilization of β-catenin by genetic defects in melanoma cell lines Science 275:1790-1792.
93. Rubinfeld, B., Souza, B., Albert, I., Munemitsu, S. and Polakis, P. (1995) The APC protein and E-cadherin form similar but independent complexes with α-catenin, β-catenin, and plakoglobin. J Biol Chem 270:5549-5555.
94. Ruch, R.J. (1994) The role of gap junction intercellular communication in neoplasia. Ann Clin Lab Sci 24:216-231.
95. Ruiter, D., Bogenrieder, T., Elder, D.E. and Herlyn, M. (2002) Melanoma-stroma interactions: Structural and functional aspects. Lancet Oncology 3:35-43.
96. Satyamoorthy, K., Li, G., Vaidya, B., Kalabis, J. and Herlyn, M. (2002) Insulin-like growth factor-1-induced migration of melanoma cells is mediated by interleukin-8 induction. Cell Growth Differ 13:1-7.
97. Satyamoorthy, K., Li, G., Vaidya, B., Patel, D. and Herlyn, M. (2001b) IGF-1 induces survival and growth in biologically early melanoma cells through both the MAP kinase and β-catenin pathways. Cancer Res 61:7318-7324.
98. Satyamoorthy, K., Meier, F., Hsu, M.-Y., Berking, C. and Herlyn, M. (1999) Human xenografts, human skin and skin reconstructs for studies in melanoma development and progression. Cancer Met Rev 18:401-405.
99. Satyamoorthy, K., Muyers, J., Meier, F., Patel, D. and Herlyn, M. (2001a) Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Oncogene 20:4676-4684.
100. Scott, G.A. and Cassidy, L. (1998) Racl mediates dendrite formation in response to melanocyte stimulating hormone and ultra-violet light in a murine melanoma model. J Invest Dermatol 111:243-250.
101. Seo, N., Hayakawa, S., Takigawa, M. and Tokura, Y. (2001) Interleukin-10 expressed at early tumor sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity. Immunology 103:449-457.
102. Shibata, Y., Kumai, M., Nishii, K. and Nakamura, K. (2001) Diversity and molecular anatomy of gap junctions. Med Electron Microsc 34:153-159.
103. Shih, I.-M., Elder, D.E., Hsu, M.-Y. and Herlyn, M. (1994) Regulation of MelCAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Pathol 145:837-845.
104. Shih, I.-M., Speicher, D., Hsu, M.-Y., Levine, E. and Herlyn, M. (1997) Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. Cancer Res 57:3835-3840.
105. Silye, R., Karayiannakis, A.J., Syrngos, K.N., Poole, S., van Noorden, S., Batchelor, W., Regele, H., Sega, W., Boesmueller, H., Krausz, T. and Pignatelli, M. (1998) E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol 186:350-355.
106. Sporn, M.B. (2000) Chemoprevention of cancer. Carcinogenesis 21:525-530.
107. St. Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K.E., Montgomery, E., Lal, A., Riggins, G.J., Lengauer, C., Volgelstein, B. and Kinzler, K.W. (2000) Genes expressed in human tumor endothelium. Science 289:1197-1202.
108. Stracke, M.L., Engrl, J.D., Wilson, L.W., Rechler, M.M., Liotta, L.A. and Schiffmann, E. (1989) The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol Chem 264:21544-21549.
109. Su, L.K., Vogelstein, B. and Kinzler, K.W. (1993) Association of the APC tumor suppressor protein with catenins. Science 262:1734-1737.
110. Takahashi, K., Eto, H. and Tanabe, K.K. (1999) Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer 80:387-395.
111. Tang, A., Eller, M.S., Hara, M., Yaar, M., Hirohashi, S. and Gilchrest, B.A. (1994) E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 107:983-992.
112. Teli, A., De Georgi, A., Apinella, M., Migliaccio, S., Canipari, R., Onetti Muda, A. and Faraggiana, T. (1997) Transforming growth factor-β enhances adhesion of melanoma cells to the endothelium in vitro. Int J Cancer 72:1013-1020.
113. Tietze, M.K. and Chin., L. (2000) Murine models of malignant melanoma. Mol Med Today 6:408-410.
114. Tosetti, F., Ferrari, N., De Flora, S. and Albini, A. (2002) Angioprevention: angiogenesis is a common and key target for cancer chemoprevention agents. FASEB J 16:2-14.
115. Toyofuku, T., Hong, Z., Kuzya, T., Tada, M. and Hori, M. (2001) Wnt-1/frizzled-2 signaling induces aggregation and adhesion among cardiac myocytes by increased cadherin-beta-catenin complex. J Cell Biol 150:225-241.
116. Tufan, A.C. and Tuan, R.S. (2001) Wnt regulation of limb mesenchymal chondrogenesis is accomplished by altered N-cadherin-related functions. FASEB J 15:1436-1438.
117. Valyi-Nagy, I.T., Hirka, G., Jensen, P.J., Shih, I.-M., Juhasz, I. and Herlyn, M. (1993) Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. Lab Invest 69:152-159.
118. Valyi-Nagy, I.T., Murphy, G.F., Mancianti, M.L., Whitaker, D. and Herlyn, M. (1990) Phenotypes and interactions of human melanocytes and keratinocytes in an epidermal reconstruction model. Lab Invest 62:314-324.
119. Van Belle, P.A., Elentitsas, R., Satyamoorthy, K., Wolfe, J., Guerry, D. IV, Schuchter, L., Van Belle, T.J., Albelda, S., Tahin, P., Herlyn, M. and Elder, D.E. (1999) Progression-related expression of β3 integrin in melanoma and nevi. Hum Pathol 30:562-567.
120. Voura, E.B., Sandig, M. and Siu, C.-H. (1998) Cell-cell interactions during transepithelial migration of tumor cells. Microsc Res Tech 43:265-275.
121. Yang, J., Luan, J., Yu, Y., Li, C., Depinho, R.A and Chin, L. (2001) Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res 61:8150-8157.